Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
Semaglutide and MBS were both associated with improvements in weight and improved glycaemic control at 2 years after the start of the intervention, but MBS was associated with better weight loss and glucometabolic control.
Authors
- Erik Stenberg (ORCID: https://orcid.org/0000-0001-9189-0093)
- Suzanne Hedberg (ORCID: https://orcid.org/0000-0001-8052-029X)
- Erik Näslund (ORCID: https://orcid.org/0000-0002-0166-6344)
- Johan Ottosson (ORCID: https://orcid.org/0000-0002-9243-2390)
- Yang Cao (ORCID: https://orcid.org/0000-0002-3552-9153)
Institutions
- Örebro University (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1111/dom.15952
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Region Örebro län
- Stockholm läns landsting